Entity family

Browse diseases

Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.

570articles mentioning diseases

2,756disease mentions

1distinct diseases extracted

0%of mentions human-reviewed

Active filtersEntity: SLE ×

SLE

This disease is selected. Its supporting articles are shown below.

Articles mentioning SLE

570 articles · page 35 of 48

PO:11:300 Evaluating DORIS remission attainment with anifrolumab in immunosuppressant- and biologic-naïve patients with SLE: design of SUNFLOWER, a phase 3b prospective study

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

98.8%

SLE DORIS anifrolumab AstraZeneca Avalere Health SUNFLOWER

…llowing subcutaneous anifrolumab initiation among patients with SLE who are naïve to conventional immunosuppressants/other biologic…

PO:11:302 Anifrolumab for systemic lupus erythematosus: preliminary safety and efficacy findings from the Italian experience

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

94.8%

Systemic Lupus Erythematosus SLE SLE-DAS Anifrolumab

…Objectives Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease. Anifrolumab, a monoclona…

PO:12:307 Group-based, telerehabilitation for executive dysfunction in systemic lupus erythematosus: a pilot study on efficacy, retention and customization of care

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

87.1%

systemic lupus erythematosus SLE Telerehabilitation

…effective, accessible cognitive interventions for patients with systemic lupus erythematosus (SLE) living remote from treatment centres and/or with mobility…

PO:12:320 Late-onset systemic lupus erythematosus: experience from a 15- Year Moroccan cohort

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

90.0%

Systemic lupus erythematosus SLE antimalarials Mohammed VI University Hospital systemic corticosteroids Conventional immunosuppressants

…Objectives Systemic lupus erythematosus (SLE) is a polymorphic connective tissue disease characterized …

PO:13:333 The quick systemic lupus activity questionnaire (Q-SLAQ) and comparison with physicians’ assessment of disease activity – explored in a real-life register study

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

87.0%

Systemic Lupus Erythematosus SLE Systemic Lupus Numeric Rating Scale SLEDAI-2K

…Objectives To compare Systemic Lupus Erythematosus (SLE) patients’ assessment of disease activity, using the Quick…

PO:13:343 Associations of lifestyle features with quality of life in patients with systemic lupus erythematosus. Results from baseline clinical data of the multi-omic multi-institutional SMILES study

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

98.3%

SLE LupusQoL lupus Rheumatology departments

…ting physical activity and health education as part of holistic SLE care.…

PO:13:345 Translation and cultural adaptation for the portuguese context of the systemic lupus erythematosus needs questionnaire

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

87.0%

Systemic Lupus Erythematosus SLE SLENQ

…Objectives Systemic Lupus Erythematosus (SLE) is a prevalent autoimmune disease characterized by divers…

PO:13:347 Caregiver in systemic lupus erythematosus: cross-sectional survey

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

99.8%

…impact of caring on their lives.Methods We involved consecutive SLE patients (ACR/EULAR 2019 criteria). We asked the patients about…

PT2:04 Glomerular hematuria and its association with kidney pathology in systemic lupus erythematosus: a matter of context

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

82.8%

glomerular hematuria systemic lupus erythematosus glomerular hematuriaConclusions SLE

…tibody positivity and low complement levels.Among patients with glomerular hematuria (n= 137), independent predictors of clinically significant LN i…

PT2:08 Serum IgA2 anti-dsDNA as a theragnostic biomarker for low disease activity with belimumab after rituximab therapy in systemic lupus erythematosus

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

99.5%

SLE belimumab rituximab prednisone hydroxychloroquine

… clinical responses to belimumab following rituximab therapy in SLE. These findings provide a feasible enrichment strategy that has…

PT3:06 Mapping neurological involvement, regional disparities, and moderators of the central nervous system in adult-onset systemic lupus erythematosus: a global systematic review and meta-analysis

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

93.0%

SLE cerebrovascular disease Aseptic meningitis CVD Systemic Lupus PubMed Scopus Cochrane Library Web of Science

…ther research to clarify factors influencing CNS involvement in SLE, refine phenotypic classification, and identify specific biomar…

PT4:02 Landmark long-term remission achieved with ICG318, a BCMA-CD19 armored compound CAR T-cell therapy, in refractory systemic lupus erythematosus/lupus nephritis with follow-up approaching 6 years

lupusscimed · abstract · 2026-03-01 · 3 matching annotations

91.2%

lupus nephritis SLE systemic lupus erythematosus ICG318 cyclophosphamide

…G318 to treat refractory systemic lupus erythematosus (SLE) and lupus nephritis (LN) in a phase I clinical trial. We report up to 67-month foll…